MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0003559
Nugenic Pharma Private Limited - packaging in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹79.17 Cr
▼ 2% YoY
Net profit · FY 2025
₹2.61 Cr
Net margin 3.3%
EBITDA · FY 2025
₹7.93 Cr
EBITDA margin 10%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.87 Cr
Issued & subscribed
Open charges
₹25.2 Cr
Satisfied ₹6.78 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
232
Provident fund records
About Nugenic Pharma Private Limited
Data last updated:
Nugenic Pharma Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the pharmaceutical packaging solutions segment of the packaging sector. It was incorporated on 09 December 2004 and has been in existence for over 22 years.
Its director Manoj Lohariwala is #1,233 among India's richest people (2026). Its director Vinay Kumar Lohariwala is #1,427 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2004PTC027717. Its GSTIN is 02AACCN1051D2ZB (Himachal Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.87 Cr. It is led by directors including Manoj Kumar Lohariwala and Vinay Kumar Lohariwala.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 69/A Epip Phase – 1 Jharmajri, Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹79.17 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.61 Cr (net margin 3.3%) and EBITDA of ₹7.93 Cr (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 3% over five years.
The company has about 232 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Innova Captab. As per MCA filings, the company has open charges of ₹25.2 Cr and satisfied charges of ₹6.78 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.99 Cr; the latest was in September 2021. The company has 13 MSME Form 1 returns on record between 2020 and 2024, listing 481 overdue payments to 32 micro and small suppliers.
Nugenic Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0003559). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovacaptab.com.
Company details
CIN U24230HP2004PTC027717
Registration Number 027717
Incorporation Date 09 December 2004
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0003559
Key People
Manoj Kumar Lohariwala Director Vinay Kumar Lohariwala Director Rohit Lohariwala Director Recognitions & Rankings of Nugenic Pharma
India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #1,233 Manoj Lohariwala ₹1,900 Cr
- #1,427 Vinay Kumar Lohariwala ₹1,500 Cr
Contact details
Nugenic Pharma Private Limited's registered office is in Baddi, Himachal Pradesh. Its website is innovacaptab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address69/A Epip Phase – 1 Jharmajri, Baddi, Himachal Pradesh, India – 173205
- IndustryPackaging, Pharmaceutical Packaging Solutions
To see the full contact details of Nugenic Pharma Private Limited, buy the company report.
Comprehensive company report
Nugenic Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nugenic Pharma operates one associated brand: Innova Captab. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations are manufactured by Innova Captab as a CDMO. | innovacaptab.com |
Business activity
The main business activity of Nugenic Pharma is manufacturing. In detail, this covers wood and wood products, furniture, paper and paper products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C3 | Wood and wood products, furniture, paper and paper products |
To see the full business activity and turnover split of Nugenic Pharma Private Limited, buy the company report.
Financials of Nugenic Pharma Private Limited
FY 2025 filings availableNugenic Pharma Private Limited reported revenue of ₹79.17 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹79.17 Cr ▼ 2%
Net profit · FY 2025
₹2.61 Cr margin 3.3%
EBITDA · FY 2025
₹7.93 Cr margin 10%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 7%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 11%
5 years · compounded
▲ 13%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.61 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nugenic Pharma Private Limited, buy the company report.
Board of directors of Nugenic Pharma Private Limited
Nugenic Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Lohariwala | Director | 09 Dec 2004 | 21 Years 10 Months | Current |
| Vinay Kumar Lohariwala | Director | 09 Dec 2004 | 21 Years 10 Months | Current |
| Rohit Lohariwala Also directs: Innoventis Medicare Limited | Director | 20 Mar 2014 | 12 Years 7 Months | Current |
| Rahul Luhariwala Also directs: Innoventis Medicare Limited | Director | 21 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Nugenic Pharma Private Limited is audited by GARG SANJEEV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG SANJEEV & ASSOCIATES | FY 2023 | 011326N |
Shareholding
The shareholding of Nugenic Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nugenic Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25.2 Cr
Satisfied charges
₹6.78 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Oct 2020 | 100378803 | Yes Bank Limited | ₹25.2 Cr | Open | |
| 01 Nov 2011 | 10320360 | State Bank of India | ₹4.58 Cr | Satisfied | |
| 25 Feb 2011 | 10319680 | Axis Bank Ltd. | ₹2.2 Cr | Satisfied |
To see the full charge records of Nugenic Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Nugenic Pharma Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.99 Cr; the latest was in September 2021.
Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹1.99 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Mar 2012 | Funding round | ₹1.83 Cr | Investors: 2 individuals |
| Mar 2007 | Funding round | ₹16 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nugenic Pharma Private Limited has 4 court cases on record: 3 filed by Nugenic Pharma, 1 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case | Filed against the company by State of Himachal Pradesh | Pending |
| High Court, HIMACHAL PRADESH | Interim or miscellaneous application | Filed by the company against Indian Bank and Others(Not Applicable) | Disposed |
| High Court, HIMACHAL PRADESH | Writ petition | Filed by the company against Indian Bank and Others(Not Applicable) and 4 others | Disposed |
To see the full case history of Nugenic Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nugenic Pharma Private Limited has 13 MSME Form 1 returns on record between 2020 and 2024, listing 481 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Durga Industries | |||
| Durga Box Co. | |||
| RRM Trading International Private Limited | |||
| P.D.S. Foils India Private Limited | |||
| Cgsasp Private Limited |
To see the full MSME payment records of Nugenic Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Nugenic Pharma Private Limited has a workforce of 232 employees on its EPFO records as of Apr 09, 2024, across 2 active EPFO establishments.
Employee count
232
Active EPFO establishments
2
Employee growth
3.11%
GST
Nugenic Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCN1051D2ZB | Himachal Pradesh | Active | 01 Jul 2017 |
| 01AACCN1051D1ZE | Jammu and Kashmir | Active | 19 Sep 2024 |
To see the full GST registrations and return filing status of Nugenic Pharma Private Limited, buy the company report.
Recent activity
Nugenic Pharma Private Limited has 8 board changes on record since 2004: 4 appointments and 4 cessations. The latest: Manoj Kumar Lohariwala ceased to be Director on 06 Sep 2022.
AGM
Nugenic Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Nugenic Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Yes Bank Limited of Rs. 25.20 Cr registered on 05 Oct 2020 with Charge ID 100378803 was modified on 22 Mar 2023.
Ceased
Manoj Kumar Lohariwala ceased to be Director.
Ceased
Vinay Kumar Lohariwala ceased to be Director.
Ceased
Rahul Luhariwala ceased to be Additional Director.
Appointed
Rahul Luhariwala was appointed as Director.
Charges
A charge registered on 01 Nov 2011 via Charge ID 10320360 with State Bank Of India was fully satisfied on 20 Oct 2020.
Charges
A charge with Yes Bank Limited amounted to Rs. 25.20 Cr with Charge ID 100378803 was registered on 05 Oct 2020.
Charges
A charge with State Bank Of India of Rs. 4.58 Cr registered on 01 Nov 2011 with Charge ID 10320360 was modified on 03 Jun 2020.
Ceased
Rohit Lohariwala ceased to be Additional Director.
Appointed
Rohit Lohariwala was appointed as Director.
6 earlier events are in the company report.
News
Frequently asked questions
Nugenic Pharma is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in pharmaceutical packaging solutions, within the packaging industry. It was incorporated on 09 December 2004 (22+ years old) and is registered under CIN U24230HP2004PTC027717.
Nugenic Pharma has 4 current directors:
- Manoj Kumar Lohariwala - Director
- Vinay Kumar Lohariwala - Director
- Rohit Lohariwala - Director
- Rahul Luhariwala - Director
The latest financial statements of Nugenic Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nugenic Pharma is 02AACCN1051D2ZB, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 01AACCN1051D1ZE (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Nugenic Pharma is U24230HP2004PTC027717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nugenic Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Nugenic Pharma was incorporated on 09 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Nugenic Pharma has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.99 Cr; the latest was in September 2021.
Manoj Kumar Lohariwala ceased to be Director on 06 Sep 2022. Vinay Kumar Lohariwala ceased to be Director on 06 Sep 2022. Rahul Luhariwala ceased to be Additional Director on 25 Nov 2021. Nugenic Pharma has 8 board changes on record in total.
Yes, Nugenic Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0003559).
Nugenic Pharma has 13 MSME Form 1 returns on record between 2020 and 2024, listing 481 overdue payments to 32 micro and small suppliers. The latest return was filed on 01 May 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages